Epitalon vs Humanin
Overview
Epitalon and Humanin are both anti-aging & longevity peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Epitalon and Humanin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Epitalon | Humanin | |
|---|---|---|
| Category | Anti-aging & Longevity | Anti-aging & Longevity |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Research use only |
| Typical dosage | 5-10 mg | Research phase |
| Frequency | cycle | research |
| Reported benefits | Areas studied (research-reported, not established efficacy): telomerase activation and telomere elongation in human cell lines (PMID 12937682; DOI 10.1007/s10522-025-10315-x); increased melatonin synthesis and circadian effects in a small human study; lower overall and cardiovascular mortality in a 12-15 year single-lab trial that used pineal extract (epithalamin), not synthetic AEDG (PMID 17426848, 22451889). No independent multi-center RCTs; not FDA-approved. | Neuroprotection, metabolic health, potential longevity extension, alzheimer's protection |
| Reported side effects | Khavinson-group trials reported no serious adverse events (e.g., n=162 retinitis pigmentosa trial, PMID 12195242), but these are the only controlled safety data and remain unreplicated. Community use reports mild injection-site reactions. Theoretical concern: telomerase activation is a hallmark of most cancers, and a 2025 review (PMC11943447) notes carcinogenic potential is unstudied. No human pharmacokinetic or drug-interaction data. | Research phase. Safety profile being established |
Key differences
Primary use. Epitalon is categorised under Anti-aging & Longevity, while Humanin falls under Anti-aging & Longevity. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Epitalon: not FDA-approved; compounding permitted with a prescription as of April 2026. Humanin: not FDA-approved; treated as a research compound.
Dosing. Epitalon is typically dosed at 5-10 mg (cycle). Humanin is typically dosed at Research phase (research).
Can you stack them?
Some protocols combine peptides, but stacking Epitalon and Humanin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Epitalon and Humanin?
- Epitalon and Humanin are both anti-aging & longevity peptides, but they differ in mechanism, dosing, and regulatory status. Epitalon is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Humanin is not FDA-approved; generally classified as a research compound.
- What is Epitalon used for?
- Longevity, telomere support.
- What is Humanin used for?
- Mitochondrial protection, longevity.
- Can you take Epitalon and Humanin together?
- Some users combine peptides within a single protocol, but stacking Epitalon and Humanin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Epitalon or Humanin FDA-approved?
- Epitalon is not FDA-approved; compounding permitted with a prescription (as of April 2026). Humanin is not FDA-approved; generally classified as a research compound.